Medistim ASA (MEDI)

Currency in NOK
236.00
-8.00(-3.28%)
Closed·
MEDI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
236.00240.00
52 wk Range
145.00292.00
Key Statistics
Prev. Close
244
Open
238
Day's Range
236-240
52 wk Range
145-292
Volume
3.5K
Average Volume (3m)
7.5K
1-Year Change
57.8595%
Book Value / Share
22.91
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
315.00
Upside
+33.47%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Medistim ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Medistim Company Profile

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Employees
154
Market
Norway

Medistim ASA Earnings Call Summary for Q3/2025

  • Revenue up 25.7% YoY to NOK 166.8M, slightly below forecast. EBIT grew 27.1% to NOK 40.6M. Stock rose 4.76% post-earnings.
  • Imaging systems now 50% of total system sales. U.S. market supports 37% of CABG procedures, remains key growth driver.
  • Gross margin improved to 81.5%. Profit after tax up 48% YoY to NOK 34.7M. Company exploring direct sales in France and Japan.
  • CEO highlights Asia-Pacific as medium to long-term growth engine. Vascular market growth slowed to 3.7%, presenting a challenge.
  • Analysts queried market acceptance of price increases, quarterly performance variations, and potential geographic expansion plans.
Last Updated: 24/10/2025, 09:18
Read Full Transcript

Compare MEDI to Peers and Sector

Metrics to compare
MEDI
Peers
Sector
Relationship
P/E Ratio
31.3x15.3x−0.6x
PEG Ratio
0.780.020.00
Price/Book
10.7x2.0x2.6x
Price / LTM Sales
6.7x1.4x3.4x
Upside (Analyst Target)
29.1%21.7%41.7%
Fair Value Upside
Unlock9.5%5.0%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 315.00
(+33.47% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.79%
Dividend Yield
2.54%
Industry Median 2.24%
Annualised payout
6.00
Paid annually
5-Years Growth
+16.89%
Growth Streak

Earnings

Latest Release
Oct 24, 2025
EPS / Forecast
1.90 / 1.60
Revenue / Forecast
166.85M / 169.50M
EPS Revisions
Last 90 days

People Also Watch

63.60
JEN
+0.63%
43.97
THR
+1.59%
46.00
NORCO
+1.88%
87.30
PARB
+1.04%
85.90
VETO
+1.18%

FAQ

What Is the Medistim (MEDI) Share Price Today?

The live Medistim share price today is 236.00

What Stock Exchange Does Medistim (MEDI) Trade On?

Medistim is listed and trades on the Oslo Stock Exchange.

What Is the Ticker (Stock Symbol) for Medistim?

The stock symbol (also called a 'ticker') for Medistim is "MEDI."

Does Medistim Pay Dividends? What’s The Current MEDI Dividend Yield?

Yes, MEDI Pays Dividends to its Shareholders. The current Medistim dividend yield is 2.54%.

What Is the Current Medistim Market Cap?

As of today, Medistim market capitalisation is 4.31B.

What Is Medistim's (MEDI) Earnings Per Share (TTM)?

The Medistim EPS is currently 7.79 (Trailing Twelve Months).

When Is the Next Medistim Earnings Date?

Medistim's next earnings report will be released on 27 Feb 2026.

Is MEDI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Medistim moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Medistim Stock Split?

Medistim has split 0 times. (See the MEDI stock split history page for full effective split date and price information.)

How Many Employees Does Medistim Have?

Medistim has 154 employees.

What is the current trading status of Medistim (MEDI)?

As of 27 Jan 2026, Medistim (MEDI) is trading at a price of 236.00, with a previous close of 244.00. The stock has fluctuated within a day range of 236.00 to 240.00, while its 52-week range spans from 145.00 to 292.00.

What Is Medistim (MEDI) Price Target According to Analysts?

The average 12-month price target for Medistim is NOK315.00, with a high estimate of NOK320 and a low estimate of NOK310. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +33.47% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.